# Kairos Pharma, LTD.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:225ba436-b482-4430-a8d2-073509e33925 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/kairos-pharma-ltd |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 13 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-24T04:47:23.804732+00:00 |
| Last reviewed | 2026-10-24T04:47:23.804732+00:00 |

## Identity

- Legal name: Kairos Pharma, LTD.
- Display name: Kairos Pharma, LTD.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-24T12:11:15.593308+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.838 |
| Directors | 4 |
| Committees | 0 |
| Governance events | 8 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Hansoo Michael Keyoung, M.D., Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-05-22. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:5
- Hyun W. Bae, M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:6
- John S. Yu, M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-05-22. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:7
- Ramachandran Murali, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-05-22. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:8

## Executive leadership

- Doug Samuelson: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:9
- John S. Yu, M.D.: Chief Executive Officer and Chairman of the Board [CEO]. Status: current. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:10
- Neil Bhowmick, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:11
- Ramachandran Murali, Ph.D.: Vice President of Research and Development. Status: current. claim_id=alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:12

## Governance events

- DIRECTOR_APPOINTED: Hansoo Michael Keyoung, M.D., Ph.D. seat on Kairos Pharma, LTD., effective 2026-05-22. Effective: 2026-05-22. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:1tts3dr1kxrl7d
- DIRECTOR_APPOINTED: John S. Yu, M.D. seat on Kairos Pharma, LTD., effective 2026-05-22. Effective: 2026-05-22. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:12o8vzvt0vm2f
- DIRECTOR_APPOINTED: Ramachandran Murali, Ph.D. seat on Kairos Pharma, LTD., effective 2026-05-22. Effective: 2026-05-22. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:7ox58k1ouk7eo
- CFO_CHANGED: Doug Samuelson executive of Kairos Pharma, LTD., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:l6l5wp1povg6n
- CEO_CHANGED: John S. Yu, M.D. executive of Kairos Pharma, LTD., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:235nf1i3mz71
- EXECUTIVE_APPOINTED: Neil Bhowmick, Ph.D. executive of Kairos Pharma, LTD., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:1hc0o2wfyy0bs
- EXECUTIVE_APPOINTED: Ramachandran Murali, Ph.D. executive of Kairos Pharma, LTD., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:1hv4ksx14r97on
- DIRECTOR_APPOINTED: Hyun W. Bae, M.D. seat on Kairos Pharma, LTD., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-24T04:47:23.804732+00:00. event_id=alpha:event:transition:1o3262d15onmph

## Scoped resources

- `alpha://company/kairos-pharma-ltd` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record
- `alpha://company/kairos-pharma-ltd/identity` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=identity
- `alpha://company/kairos-pharma-ltd/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=corporate-structure
- `alpha://company/kairos-pharma-ltd/board` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=board
- `alpha://company/kairos-pharma-ltd/committees` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=committees
- `alpha://company/kairos-pharma-ltd/leadership` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=leadership
- `alpha://company/kairos-pharma-ltd/ownership` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=ownership
- `alpha://company/kairos-pharma-ltd/financials` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=financials
- `alpha://company/kairos-pharma-ltd/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=capital-structure
- `alpha://company/kairos-pharma-ltd/compensation` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=compensation
- `alpha://company/kairos-pharma-ltd/governance` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=governance
- `alpha://company/kairos-pharma-ltd/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=shareholder-governance
- `alpha://company/kairos-pharma-ltd/audit` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=audit
- `alpha://company/kairos-pharma-ltd/legal` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=legal
- `alpha://company/kairos-pharma-ltd/risk` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=risk
- `alpha://company/kairos-pharma-ltd/cyber` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=cyber
- `alpha://company/kairos-pharma-ltd/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=ai-governance
- `alpha://company/kairos-pharma-ltd/agents` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=agents
- `alpha://company/kairos-pharma-ltd/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=ecosystem
- `alpha://company/kairos-pharma-ltd/events` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=events
- `alpha://company/kairos-pharma-ltd/relationships` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=relationships
- `alpha://company/kairos-pharma-ltd/assessments` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=assessments
- `alpha://company/kairos-pharma-ltd/evidence` (contract): https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Hansoo Michael Keyoung, M.D., Ph.D.: Director. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:5. Valid from: 2026-05-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7bf2b28d019c8337431c49e943a5db3e023541b0cdc698fc51bbdb2962fd0ad2.
- Hyun W. Bae, M.D.: Director. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7bf2b28d019c8337431c49e943a5db3e023541b0cdc698fc51bbdb2962fd0ad2.
- John S. Yu, M.D.: Director. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:7. Valid from: 2026-05-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7bf2b28d019c8337431c49e943a5db3e023541b0cdc698fc51bbdb2962fd0ad2.
- Ramachandran Murali, Ph.D.: Director. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:8. Valid from: 2026-05-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7bf2b28d019c8337431c49e943a5db3e023541b0cdc698fc51bbdb2962fd0ad2.
- Doug Samuelson: Chief Financial Officer. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:9. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0b21f43fa5cf46ec5718a7f5943caf083bb8b5b601890e64838d38796d3ff327.
- John S. Yu, M.D.: Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:10. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9a72d91c66f31d6222b32d78fef06225b0305fba69d1cf2ca6bb3e1ea24ea9a6.
- Neil Bhowmick, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:11. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c623f21d3cb671df064849564aae10c0914ba59c7431db9b7b17eacfccd225b0.
- Ramachandran Murali, Ph.D.: Vice President of Research and Development. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:leadership_role:12. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f8535bde0ea93ade0556a88107e3349355a7faf3f6b641f8ff86c63512068fff.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Kairos Pharma, LTD.. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca7db3e64dc5e4ce76d912e66aba4fc34652d73fded7eb60893069517b38458a.

## Entity Status

- Public listing published. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca7db3e64dc5e4ce76d912e66aba4fc34652d73fded7eb60893069517b38458a.

## Published Fact

- US. Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca7db3e64dc5e4ce76d912e66aba4fc34652d73fded7eb60893069517b38458a.

## Security Listing

- KAPA (NYSE). Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:security_listing:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca7db3e64dc5e4ce76d912e66aba4fc34652d73fded7eb60893069517b38458a.
- KAPA (NYSE AMERICAN). Claim: alpha:claim:company:225ba436-b482-4430-a8d2-073509e33925:security_listing:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ca7db3e64dc5e4ce76d912e66aba4fc34652d73fded7eb60893069517b38458a.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:ca7db3e64dc5e4ce76d912e66aba4fc34652d73fded7eb60893069517b38458a: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/kairos-pharma-ltd).
- alpha:projection-evidence:document:7bf2b28d019c8337431c49e943a5db3e023541b0cdc698fc51bbdb2962fd0ad2: [DEF 14A formdef14a.htm](https://www.sec.gov/Archives/edgar/data/1962011/000149315226025020/formdef14a.htm).
- alpha:projection-evidence:document:0b21f43fa5cf46ec5718a7f5943caf083bb8b5b601890e64838d38796d3ff327: [KAPA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1962011/000149315226014159/form10-k.htm).
- alpha:projection-evidence:document:9a72d91c66f31d6222b32d78fef06225b0305fba69d1cf2ca6bb3e1ea24ea9a6: [KAPA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1962011/000149315226014159/form10-k.htm).
- alpha:projection-evidence:document:c623f21d3cb671df064849564aae10c0914ba59c7431db9b7b17eacfccd225b0: [KAPA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1962011/000149315226014159/form10-k.htm).
- alpha:projection-evidence:document:f8535bde0ea93ade0556a88107e3349355a7faf3f6b641f8ff86c63512068fff: [KAPA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1962011/000149315226014159/form10-k.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/kairos-pharma-ltd)
- [Public Markdown](https://registry.alpha.ac/companies/kairos-pharma-ltd.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/kairos-pharma-ltd?format=jsonld)
- MCP resource: `alpha://companies/kairos-pharma-ltd` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-24T12:11:15.348217+00:00; recorded 2026-10-24T12:11:15.348217+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.